In this study, hybrid nanofibrous scaffolds composed of PLCL and bioactive factors secreted by Wharton’s jelly-derived mesenchymal stem cells were fabricated
via co-electrospinning. 2026
Multipurpose
platforms
Medical
platforms
Development
services














































